Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT)

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03184649
Collaborator
(none)
52
1
3
7
7.4

Study Details

Study Description

Brief Summary

The Effect of Ibuprofen, Paracetamol versus Placebo on Pain during Local Anesthetic Injection and Following Dental Extraction in Primary Molars: A Randomized clinical trial

Condition or Disease Intervention/Treatment Phase
Phase 1/Phase 2

Detailed Description

  1. Diagnosis:

  2. Diagnostic chart will be filled with personal, medical and dental history. DMF and def.

  3. Clinical examination (intra oral and extra oral) will be done by mirror and probe to assess the inclusion criteria. All materials will be packaged in sterilizations wraps and autoclave following the required bio safety standards.

  4. Intervention:

Experimental Groups:

Group 1: Ibuprofen suspension (Ibufen®, 100 mg/5 mL; fruit flavored, orange colour, Abbott). Group 2: Paracetamol (Calpol™, 250 mg/5 mL; fruit flavored, orange color, GlaxoSmithKline).

Comparative Group:

Group 3: A fruit-flavored orange color placebo solution.

Clinical procedure:
  1. The drugs in all of the groups will be prepared in a fruit-flavored solution of the same color and scent.

  2. Patients will be blind to one of the three pre-treatment drug groups.

  3. Containers of each solution will be prepared and number-coded with the slips of paper by the assistant supervisor. The containers will be the same for all treatment groups except for the number coded with slips of paper.

  4. Both the researcher and the child/parent will be blind to the content of the container.

  5. The assigned solution will be taken by the patient at various times before administration of the local anesthetic agent. Ibuprofen 30 min before injection of local anesthesia paracetamol 60 min before injection of local anesthesia Placebo solution 60 min before injection of local anesthesia

  6. The time of the preoperative solution administration will be recorded on the data sheet.

  7. Topical anesthesia in the form of benzocaine gel 20% will be applied to the dried mucosa. All the children will be given 2% lidocaine with a 1:80,000 epinephrine injection for local anesthesia sufficient for obtaining adequate anesthesia.

  8. All teeth will be extracted with a minimum of surgical trauma in an uncomplicated fashion.

Recording data

  1. Pain scores will be recorded in the Pediatric Dental Clinic using a five-face scale that had been previously validated.

  2. This scale has shown good construct validity as a self-report pain measure. It measures an affective dimension of a child's pain experience after injection and teeth extraction and is used in children aged 7-12 years.

  3. It is easy to use and giving consistent scores from 0 to 4. It can be used for the subjective evaluation of feelings after the performance of painful dental procedures.

  4. The child will be shown to a set of five cartoon faces with varying facial expressions ranging from a smile/laughter to tears. The scores given are: (0) No sign of pain. (1) Mild pain. (2) Moderate pain. (3) Severe pain. (4) Very severe pain.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
three groups, two for intervention and one for comparative groupthree groups, two for intervention and one for comparative group
Masking:
None (Open Label)
Masking Description:
statistician will be blind only
Primary Purpose:
Prevention
Official Title:
The Effect of Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection and Following Dental Extraction in Primary Molars: A Randomized Clinical Trial
Actual Study Start Date :
May 1, 2017
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention arm

Ibuprofen suspension (Ibufen®, 100 mg/5 mL; fruit flavored, orange colour, Abbott) will be given 30 min before injection of local anesthesia. Then pain scores will be recorded from 0-4.

Drug: Ibuprofen
It is a pre-analgesic will be taken before painful procedures.
Other Names:
  • Ibufen®
  • Experimental: intervention

    Paracetamol (Calpol™, 250 mg/5 mL; fruit flavored, orange color, GlaxoSmithKline) will be given 60 min before injection of local anesthesia.Then pain scores will be recorded from 0-4.

    Drug: paracetamol
    it is a pre-analgesic drug will be taken before painful procedure.
    Other Names:
  • calpol®
  • Placebo Comparator: comparator

    A fruit-flavored orange color placebo solution will be given 60 min before injection of local anesthesia.Then pain scores will be recorded from 0-4.

    Dietary Supplement: A fruit-flavored orange color placebo solution
    orange juice as a comparative group.
    Other Names:
  • orange juice
  • Outcome Measures

    Primary Outcome Measures

    1. categorical score [1 hour]

      mild, moderate, sever, very sever

    Secondary Outcome Measures

    1. binary [1 day]

      yes or no

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Children aged 7-12 years who need extractions under local anesthesia.

    2. Those having a parent/guardian to understand and comply with the requirements of the protocol and able to fill an appropriate written informed consent.

    3. Children and parents who agree to wait for the stipulated time before and after the extraction.

    Exclusion Criteria:
    1. Children with acute pain.

    2. Patients taking analgesics within 5 hours prior to the dental extraction.

    3. Patients with a history of prolonged bleeding, platelet disorders, hypersensitivity, or allergic reactions to analgesics or any of the drugs tested.

    4. Patients without a home telephone or without parental supervision for the post- operative period.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Dentistry Cairo Egypt 02

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Study Director: fatma A. Elshehaby, Professor, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Rehab Abdelrahman Elshenawy, Principle investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03184649
    Other Study ID Numbers:
    • RAElshenawy
    First Posted:
    Jun 12, 2017
    Last Update Posted:
    Jun 14, 2017
    Last Verified:
    Jun 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 14, 2017